Anne Durand

Anne Durand

Auto-generated profile, based on publicly available information

Anne Durand

Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2008 in Biochemistry
Verified
Journal Article
Closed access
COCédric Orelle
Cédric Orelle
FGFrancesca Gubellini
Francesca Gubellini
ADAnne Durand
Anne Durand
SMSergio Marco
Sergio Marco
DLDaniel Lévy
Daniel Lévy
JJJean-Michel Jault
Jean-Michel Jault

13 November 2014 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
ADAnne Durand
Anne Durand
FCFabien Chauveau
Fabien Chauveau
TCTae-Hee Cho
Tae-Hee Cho
CKChristopher Kallus
Christopher Kallus
MWMickael Wagner
Mickael Wagner
NNNorbert Nighoghossian
Norbert Nighoghossian
Background: Since thrombolysis is the only approved intervention for ischemic stroke, improving its efficacy and safety is a therapeutic aim of considerable interest. The activated form of thrombin activatable fibrinolysis inhibitor (TAFI) has antifibrinolytic effects, and inhibition of TAFI might thus favor recanalization. The present study compared efficacy between TAFI inhibition alone and TAFI inhibition in combination with rtPA at a suboptimal dose, in a murine model of thromboembolic stroke. Methods: Focal ischemia was induced in mice by thrombin injection in the middle cerebral artery. Animals were placed within the magnet immediately after surgery for baseline MRI (H0). MRI examination comprised diffusion-weighted imaging (DWI), perfusion-weighted imaging (PWI), and T2-weighted imaging (T2-WI). Animals were randomly assigned to 1 of 5 treatment groups: saline, rtPA 5 mg/kg (tPA5: suboptimal or low dose), rtPA 10 mg/kg (tPA10: standard dose), TAFI-I 100 mg/kg (TAFI-I), and rtPA 5 mg/kg + TAFI-I 100 mg/kg (tPA5 + TAFI-I). Treatments were administered inside the magnet, via a catheter placed in the tail vein, using a power injector, as 10% bolus and 90% infusion over a period of 20 min. MRI examination was repeated at 3 h (H3) and 24 h (H24) after surgery. Therapeutic benefit was evaluated by: (1) improvement of reperfusion and (2) reduction in final lesion size. Microhemorrhages were assessed as black spots on T2-WI at H24. Animals were sacrificed after the last MR examination. The surgeon and all investigators were blinded to treatment allocation. Results: A total of 104 mice were operated on. Forty four of these were excluded from the study and 27 from the analysis, according to a priori defined criteria (no lesion or no mismatch), leading to the following distribution: saline (n = 6), tPA5 (n = 8), tPA10 (n = 7), TAFI-I (n = 7), and TAFI-I + tPA5 (n = 5). Standard-dose rtPA treatment (tPA10) significantly improved lesion regression between H0 and H24 compared to saline (-57 ± 18% vs. -36 ± 21%, p = 0.03), which treatment with rtPA5 or TAFI-I alone did not. On the other hand, combined treatment with tPA5 + TAFI-I showed only a trend toward lesion regression (-49 ± 26%), similarly to treatment with tPA10, but not significantly different from saline (p = 0.46). Nine animals showed microhemorrhage on T2-WI at H24. These animals were evenly distributed between groups. Conclusions: The present study showed that the combination of TAFI-I with a suboptimal dose of rtPA is not as effective as the standard dose of rtPA, while TAFI inhibition alone is not effective at all. The thromboembolic model is of particular interest in assessing rtPA association to improve thrombolysis, especially when coupled with longitudinal MRI assessment.

1 November 1991 in Physical Therapy
Verified
Journal Article
Open access
PDF file
ADAnne Durand
Anne Durand
FMFrancine Malouin
Francine Malouin
CRCarol L Richards
Carol L Richards
GBGina Bravo
Gina Bravo
Intertrial reliability of work measurements was studied in 19 men with a partial medial meniscal tear (ME group) and in 10 men with no history of knee injury (control group). Three maximal voluntary concentric contractions of the muscles involved in knee extension (KE) and knee flexion (KF) were performed on a dynamometer at 30° and 180°/s using a preloading protocol. The subjects moved their legs through an arc of 90 degrees, and the work produced in the constant-velocity phase between 70 and 20 degrees of KE was computed for each trial. In ME group subjects able to perform three consecutive contractions (n=12–14), high intertrial intraclass correlation coefficients (ICCs) were found (ICCs=.86–.92), except for KE work measurements at 180°/s (ICC=.67). In the control group subjects, high ICCs were obtained for KE work measurements (ICCs=.87 and .95), whereas the low ICCs obtained for KF work measurements (ICCs=.64 and .79) increased to .86 and .93 when the first trial was removed. In both groups, a significant increase was found over the trials for KF measurements at 180°/s and KE measurements at 30°/s, but work measurements were shown to peak at the second trial. The results of this study suggest that the work produced on the second trial reflects a subject's maximal capacity.

10 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMonis Athar Khan
Monis Athar Khan
ADAnne Durand
Anne Durand
ASAnne Soisig Steunou
Anne Soisig Steunou
SLSolène Leleux
Solène Leleux
CCCorinne Cassier-Chauvat
Corinne Cassier-Chauvat
SOsoufian ouchane
soufian ouchane
Cyanobacteria are unique among prokaryotes in possessing photosynthetic thylakoid membranes enclosing an internal lumen, where superoxide production is expected to be substantial. Thylakoid-associated superoxide dismutases (SODs) would seem the obvious first line of defense, yet many cyanobacteria rely instead on a single soluble cytoplasmic enzyme, raising the question of what role thylakoid-associated SOD isoforms actually play. Using Cyanothece sp. PCC 7425, which encodes both a cytoplasmic FeSOD and a thylakoid-associated MnSOD, we combined sequence analysis, structural, genetics, and biochemical approaches to characterise FeSOD and MnSOD cellular localisation and assess each enzyme’s contribution to superoxide defense. Cyanobacterial MnSODs display diverse N-terminal architectures, consistent with soluble, transmembrane, or lipid-anchored forms, yet contribute only modestly to superoxide defense in Cyanothece PCC 7425 and, very likely, across cyanobacteria broadly. Soluble FeSOD instead provides the major line of defense, showing that thylakoid association does not guarantee physiological importance. This predominance of a cytoplasmic enzyme highlights the central role of cytoplasmic superoxide detoxification, consistent with superoxide being generated mainly at the PSI acceptor side, and extends to the chloroplast stroma of plants. Our findings support a model in which SOD distribution reflects metal availability, enzyme properties, and subcellular organisation : FeSOD protects the compartment harbouring the main targets of PSI-associated superoxide, whereas MnSOD is retained where thylakoid association offers additional local protection, but becomes dispensable when the local ROS burden is limited. Spatial matching between superoxide production, antioxidant localisation, and target vulnerability may thus shape the diversification and maintenance of antioxidant systems across cyanobacteria and chloroplasts.